Actively personalized vaccination trial for newly diagnosed glioblastoma
2018 · Nature · 897 citations
https://doi.org/10.1038/s41586-018-0810-y
A
Arie Admon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
220
Papers
17.7K
Citations
65
h-index
141
i10-index
Arie Admon is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Immunotherapy and Immune Responses & vaccines and immunoinformatics approaches & Peptidase Inhibition and Analysis. The author has an h-index of 65, co-authored 187 publications.
ORCID: 0000-0003-0504-3950Papers by this author
worksThe E2 Ubiquitin-conjugating Enzymes Direct Polyubiquitination to Preferred Lysines
2010 · Journal of Biological Chemistry · 178 citations
https://doi.org/10.1074/jbc.m109.089003
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
2020 · Nature Communications · 153 citations
https://doi.org/10.1038/s41467-020-14639-9
Acrylamide acute neurotoxicity in adult zebrafish
2018 · Scientific Reports · 107 citations
https://doi.org/10.1038/s41598-018-26343-2
Identification of Glypican as a Dual Modulator of the Biological Activity of Fibroblast Growth Factors
1997 · Journal of Biological Chemistry · 104 citations
https://doi.org/10.1074/jbc.272.19.12415
Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Polymorphism Relevant to Inflammatory Disease Shapes the Peptidome of the Birdshot Chorioretinopathy-Associated HLA-A*29:02 Antigen*
2015 · Molecular & Cellular Proteomics · 66 citations
https://doi.org/10.1074/mcp.m115.048959
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat